Back

Improving outcomes in HFpEF with GLP-1 receptor agonist

29 August 2026 (10:20 - 10:30)
Organised by: Logo
Congress Presentation Part of: Disease of the thick heart: case-based discussion Cardiac Hypertrophy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Leslie Cho

Cleveland Clinic, Cleveland (United States of America)

4 More presentations in this session

Presentation thumbnail
Brave new world of precision diagnosis and therapies
Doctor M. Desai (Cleveland, US)
Slides
Presentation thumbnail
Phenotypic convergence or causal cascade: stenosis, disarray, and infiltration
Professor W. Jaber (Cleveland, US)
Slides
Presentation thumbnail
The enzyme enigma
Doctor S. Keen (Cleveland, US)
Presentation thumbnail
Disease of the thick heart - panel discussion

Access the full session

Session thumbnail
Disease of the thick heart: case-based discussion

The Event

Event poster

ESC Congress 2026

29 August 2026 10:20 CET
You may be interested in
thumbnail
Webinar
GLP-1 RAs and HFpEF : what do we know from large RCTs about GLP-1 RAs and their effects on HFpEF?
24 November 2025
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025
thumbnail
Congress Session
Clinical translation of GLP-1RAs for adiposity-driven HFpEF: from guidelines to practice
30 August 2026
thumbnail
Congress Session
HFpEF: modern approaches to diagnosis and management
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources